REPORTS

Global Immunotherapy Drugs Market Size Study, by Type of Drugs (Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha & Beta, Interleukins, Others) by Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others) by End-Use (Hospitals, Clinics, Others) by Regional Forecasts 2018-2025

Publishing Date : 15 May 2019 Report Code : Bizwit_1622 Pages : 200 Category : Healthcare and Pharma
Description

Global immunotherapy drugs market is valued approximately USD billion in 2017 and is anticipated to grow with a healthy growth rate of more than 15.2% over the forecast period 2018-2025. Key driving factors of the market are increasing prevalence of life-style oriented diseases, early drug approval processes coupled with increasing adoption of targeted therapies. However, high cost of treatment is expected to hamper the market growth over the forecast period. Increasing prevalence of cancer is one of the significant factors which is driving global immunotherapy drugs market during the forecast period. According to the World Cancer Report, Cancer rates are expected to increase by 50% in the year 2020 reaching a total of 15 million patients. Regionally, the global immunotherapy market is dominated by North America region valued about $45.9 billion in 2017 that is estimated to reach about $115.9 billion by 2025. North America is followed by Europe, holding the second highest position in global immunotherapy drugs market with 29.0 billion revenues in 2016. These regions account for the highest prevalence of cancer. Furthermore, increasing number of clinical trials and drug approvals in these regions are fueling the market growth. The growth of European market is driven by increasing R&D investments from both public and private sectors. Furthermore, significant growth in drug approvals by European Medicines Agency and strong presence of key players is driving the market growth. However, Asia Pacific is anticipated to grow at the highest CAGR of 18.0% over the forecast period. Rising prevalence of cancers and extensive R&D towards the development of low-cost treatment is anticipated to drive significant opportunities in the APAC immunotherapy drugs market. On the basis of end-use, the global immunotherapy drugs market is segmented into hospitals, clinics and others. Currently, hospitals segment holds the largest revenue share. Global immunotherapy drugs market in hospitals valued at USD 68.3 billion in 2017 and is anticipated to reach USD 202.3 billion by 2025 growing at a CAGR of 14.5%. Market player included in this report are: F.Hoffmann-LA Roche AG Merck & Co., Inc. Novartis International AG Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.) GlaxoSmithKline PLC Amgen Inc. AbbVie AstraZeneca Bristol-Mysers Squibb ELI Lilly & Company The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Type of Drugs: Monoclonal Antibodies Adult Vaccines Checkpoint Inhibitors Interferons Alpha & Beta Interleukins Other Drugs By Therapy Area: Cancer Autoimmune & Inflammatory Diseases Infectious Diseases Other Therapy Area By End-Use: Hospitals Clinics Other End Users By Regions: North America U.S. Canada Europe UK Germany Asia Pacific China India Japan Latin America Brazil Mexico Rest of the World Furthermore, years considered for the study are as follows: Historical year - 2015, 2016 Base year - 2017 Forecast period - 2018 to 2025 Target Audience of the Global Immunotherapy Drugs Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors

Table of Figures

List of Tables TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF IMMUNOTHERAPY DRUGS MARKET TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF IMMUNOTHERAPY DRUGS MARKET TABLE 3. IMMUNOTHERAPY DRUGS MARKET, REPORT SCOPE TABLE 4. YEARS CONSIDERED FOR THE STUDY TABLE 5. EXCHANGE RATES CONSIDERED TABLE 6. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD MILLION) TABLE 7. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD MILLION) TABLE 8. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 9. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 10. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 11. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 12. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 13. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 14. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 15. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 16. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 17. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 18. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 19. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 20. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 21. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 22. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 23. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 24. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 25. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 26. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 27. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 28. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 29. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 30. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 31. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 32. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 33. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 34. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 35. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 36. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 37. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 38. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 39. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 40. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 41. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 42. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 43. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 44. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 45. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 46. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 47. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 48. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 49. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 50. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 51. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 52. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 53. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 54. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 55. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 56. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 57. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 58. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 59. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 60. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 61. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 62. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 63. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 64. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 65. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 66. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 67. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 68. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 69. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 70. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 71. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 72. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 73. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 74. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 75. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 76. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 77. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 78. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 79. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 80. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 81. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 82. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 83. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 84. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 85. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 86. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 87. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 88. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 89. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 90. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 91. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 92. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 93. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 94. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 95. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 96. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 97. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 98. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 99. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 100. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 101. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 102. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 103. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 104. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION) TABLE 105. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 106. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 107. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION) TABLE 108. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)